Explore

Innovations

                                        
                                    Published
                            
                Healthcare & Pharmaceuticals
            
T Cell-Exclusive COVID Vaccine
                
This technology is a COVID-19 vaccine that exclusively elicits T-cell responses without antibody responses. This design ensures sustained protection against various strains of SARS

By
                            Georgia State University
                        
Reference Number  
                11356
            
Last Update  
                 Nov 20, 2024
            
                                    Published
                            
                Medical
            
Treating T-Cell Malignancies
                Dr. Pellicer has recently discovered a new oncogene, human rgr (hrgr), whose over expression or alteration has been found to occur in a subset of non-Hodgkin lymphomas.
            
By
                            Ananda Ghosh
                        
Reference Number  
                04421
            
Last Update  
                 Nov 15, 2021
            
Do you have an innovative technology, product or service?
            Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.

View all

Keep your eye on the ball, subscribe to our email marketing to stay up to date with LEO.